Preparation and equipment
Undertake a thorough assessment of the patient, including the reason for the nasograstic (NG) tube, the type and size (French (Fr)) of NG tube required and the patient suitability to undergo the procedure at the bedside. Assessment should include previous nasal injuries and history of a pharyngeal pouch or oesophageal strictures, since these may make blind placement of the NG tube more difficult. It should also be decided which nostril it is best to use for the NG tube placement. Explain the procedure to the patient and what is expected of them. The patient must provide verbal consent. Where the patient is unable to give their consent, a capacity assessment should be undertaken. Multidisciplinary discussion is essential to ensure the procedure is undertaken in the patient's best interest. Assist the patient to sit in a semi-upright position in a bed or chair. Support the patient's head with pillows and adjust the height of equipment to avoid overstretching. Ensure all necessary equipment is functioning, in date and in reach. Adhere to local and national infection control policies and NG tube insertion guidance. The nurse should ensure that all equipment for the procedure is available, including:
-Non-sterile gloves and an apron. Note: The use of an electromagnetic tracking device for checking the position of a nasogastric tube and use of a nasal bridle to secure a nasogastric tube will not be discussed, since both require specialist equipment and training, and are beyond the scope of this article.
Procedure
1. Insertion of a NG tube is a clean procedure, so the nurse must wash their hands before the procedure and put on non-sterile gloves and an apron (National Nurses Nutrition Group (NNNG) 2012). 2. Create a clean area by opening a sterile dressing pack and placing a 60mL enteral syringe, scissors and CE-marked pH indicator strips on it. 3. Gently remove the NG tube from its packaging by holding both ends of the tube before they spring apart. Carefully unwind the tube. 4. If using a polyurethane tube with a guidewire, ensure the guidewire is firmly secured at the tip of the tube. Ensure any additional ports are closed. 5. Check the patient is in a semi-upright position and has a glass of drinking water with a drinking straw if the patient is not nil by mouth, and that tissues are within their reach. A receiver should also be placed nearby in case the patient vomits. 6. Estimate the length of NG tube to be inserted into the patient to reach the stomach using the nose-earlobe-xiphisternum (NEX) measurement as a guide (Figure 1 ) (National Patient Safety Agency (NPSA) 2011). Hold the exit port of the NG tube at the tip of nose (N), extend the length of the tube to one of the earlobes (E) and then, holding the tube at the earlobe, extend the remaining length of the NG tube to the xiphisternum (X). 7. Record the NEX measurement or mark the NG tube with a marker pen at the NEX measurement, to indicate the minimum length of tube required to reach the stomach. It is important to remember that this measurement is only a guide. It is likely that the NG tube will need to be advanced beyond the measurement indicated to ensure it sits within the lower body of the stomach. 8. Ask the patient to blow their nose into a tissue.
Where this is not possible, clean the external area around the nostrils with a damp cloth. 9. Activate the lubricant at the tip of the NG tube by dipping the end in water, or adhering to the manufacturer's guidance. The water should be sterile or freshly run tap water, according to local policy. Do not use lubricating jelly.
10. Gently insert the tip of the NG tube into the agreed nostril, sliding it slowly along the floor of the nasopharynx, into the oropharynx and hypopharynx, through the oesophagus and into the stomach (Figure 2) .
Estimation of the nasogastric tube length using the nose-earlobe-xiphisternum (NEX) measurement
FIGURE 1
Place the tip of the nasogastric tube at the tip of the nose, then measure from the nose to the ear lobe and down to the tip of the xiphisternum the fluid obtained has a pH greater than 5.5, an X-ray is required to confirm the position of the distal end of the NG tube. At this point, the NG tube must not be used to administer any feed, fluid or medication. 24. Once the gastric position is confirmed, remove the guidewire and secure the NG tube to the nose and cheek using hypoallergenic tape. Flush the NG tube with 20-30mL water to
Possible nasogastric tube misplacements that may result in retrieval of gastric aspirate with a pH greater than 5.5
FIGURE 3
Tube misplaced into the lung 
Evidence base
National guidance is available from the National Patient Safety Agency (NPSA 2005 (NPSA , 2011 (NPSA , 2012 and the National Nurses Nutrition Group (NNNG 2012) to promote safe insertion of a NG tube at the bedside. Nurses are the main group of healthcare professionals responsible for the insertion of a NG tube at the patient's bedside. Insertion of an NG tube at the bedside does not require anaesthesia, specialist equipment or surgical intervention. Therefore, it is the first-line route to provide enteral feeding. NG tubes are inserted daily without incident (NNNG 2012). However, complications have been reported (Adeyemo et al 2007 , Lyske 2011 , Paul 2013 . One risk associated with bedside placement is the inadvertent misplacement of the NG tube into the bronchial tract (Figure 3) . If NG tube misplacement is detected and the NG tube is removed, it should cause the patient no harm. There is potential to cause patient harm or death where misplacement is not detected and the NG tube is subsequently used. Use of a misplaced NG tube became a 'never event ' in 2009 ' in (NPSA 2009 ). National advice is available to guide the insertion of NG tubes and checking procedures (NPSA 2011 , NNNG 2012 , and to prevent the use of a NG tube placed outside the stomach.
Between 2005 Staff inserting NG tubes should be trained and assessed as competent to insert a NG tube and check gastric position safely. Doctors checking X-rays to confirm gastric placement should also be trained and assessed as competent. pH indicator paper used to check gastric aspirate should be CE-marked for use on human aspirate.
An ongoing programme of audit should be implemented to monitor practice.
Organisational policies and clinical guidance should reflect the advice from both NPSA (2005, 2011) alerts. A third NPSA alert (2012) was released in response to reported incidents of patient harm as a result of NG tubes that had been flushed with water before confirming gastric position. It was reported that in some NG tubes, activating the inner lubricant (coating the inner lumen of the tube which ensures easier guidewire removal) by flushing the tube with water resulted in fluid being withdrawn that gave a pH reading of under 5.5 (NPSA 2012). Therefore no fluid should be inserted into a NG tube until gastric position has been confirmed.
The accuracy of the NEX measurement has been questioned (Taylor et al 2014) and considered to be misleading. Some authors recommend using the NEX and adding 10cm to the measurement to reach the body of the stomach (Taylor et al 2014) . The NEX measurement only takes the tube to the tip of the xiphisternum; it may be a suitable measure for some patients, but it should not assumed to be an appropriate measure for all patients. When using the NEX measure, it may still be necessary to manipulate the tube to obtain gastric aspirate. Use of the NEX measurement remains the advice given by the NPSA.
The most important point to remember is that if it cannot be confirmed that the tip of the NG tube is in the stomach, it must not be used to administer any type of fluid NS
